Milestone Scientific Inc. (MLSS) Stock Price & Analysis
Milestone Scientific Inc. (MLSS) rose 0.06% to USD 0.47 as of September 8, 2026 at 07:35 UTC, according to Nexqual real-time market data.
MLSS last closed at USD 0.47; the session ranged USD 0.45–0.47 on volume of 37,780 shares. Market capitalization is —, with a 52-week range of USD 0.22–0.64 (ASE). Source: Nexqual, September 8, 2026 at 07:35 UTC.
Key Statistics (as of September 8, 2026 at 07:35 UTC)
| Price | USD 0.47 |
|---|---|
| Change | ▲ 0.06% (up) |
| Previous Close | USD 0.47 |
| Open | USD 0.47 |
| Day Range | USD 0.45 – 0.47 |
| 52-Week Range | USD 0.22 – 0.64 |
| Volume | 37,780 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (MLSS)
Nexqual's technical model rates MLSS "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 07:35 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.38 (neutral) |
| vs SMA50 | Above (USD 0.43) |
| MACD | 0.01 (positive) |
From Milestone Scientific Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary DPS Dynamic Pressure Sensing Technology allows the CompuFlo Epidural System to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify and confirm placement in the epidural space.   Our CompuFlo Epidural System provides an objective tool that we believe consistently and accurately identifies the epidural space by detecting the difference in pressure between the ligamentum flavum and the intradural tissue.
- Class I devices are those devices whose safety and effectiveness can reasonably be ensured through general controls, such as adequate labeling, pre-market notification, and adherence to the FDA's Quality System Regulation ("QSR"), also referred to as "Good Manufacturing Practices" ("GMP") regulations.
- The Company's products, including the Wand® STA System, dental handpieces used with the Wand® and Wand® STA Systems, which are classified as Class IIa medical devices and the CompuFlo® Epidural System, which is classified as a Class IIb medical device, are currently authorized for sale in the European Union under certificates issued pursuant to the former European Medical Devices Directive ("MDD").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RVP | Retractable Technologies, Inc. | USD 0.71 | ▼ 1.28% |
| INFU | InfuSystems Holdings, Inc. | USD 12.24 | ▲ 0.82% |
| PAVM | PAVmed Inc. | USD 5.28 | ▼ 1.31% |
| VNRX | VolitionRX Limited | USD 0.35 | ▼ 8% |
| IMDX | Insight Molecular Diagnostics I | USD 4.13 | ▲ 2.99% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:35 UTC. This page is informational and not investment advice.